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Abstract
Background—Body composition changes with aging lead to increased adiposity and decreased 
muscle mass, making the diagnosis of obesity challenging. Conventional anthropometry, including 
body mass index (BMI), while easy to use clinically may misrepresent adiposity. We determined 
the diagnostic accuracy of BMI using dual energy x-ray absorptiometry (DEXA) in assessing the 
degree of obesity in older adults.
Methods—The National Health and Nutrition Examination Surveys 1999–2004 were used to 
identify adults aged ≥60years with DEXA measures. They were categorized (yes/no) as having 
elevated body fat by gender (men≥25%; females ≥35%) and by body mass index (BMI) ≥25 and 
≥30kg/m2. The diagnostic performance of BMI was assessed. Metabolic characteristics were 
compared in discordant cases of BMI/body fat. Weighting and analyses were performed per 
NHANES guidelines.
Results—We identified 4,984 subjects (men:2,453; female:2,531). Mean BMI and % body fat 
was 28.0kg/m2 and 30.8% in men, and 28.5kg/m2 and 42.1% in females. A BMI ≥30kg/m2 had a 
low sensitivity and moderately high specificity (men:32.9% and 80.8%, concordance index 0.66; 
females:38.5% and 78.5%, concordance 0.69) correctly classifying 41.0 and 45.1% of obese 
subjects. A BMI ≥25kg/m2 had a moderately high sensitivity and specificity (men:80.7% and 
99.6%, concordance 0.81;females:76.9% and 98.8%, concordance 0.84) correctly classifying 80.8 
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and 78.5% of obese subjects. In subjects with BMI<30kg/m2 body fat was considered elevated in 
67.1% and 61.5% of males and females, respectively. For a BMI≥30kg/m2, sensitivity drops from 
40.3 to 14.5% and 44.5 to 23.4%, while specificity remains elevated (>98%),in males and females, 
respectively in those 60–69.9years to subjects aged ≥80years. Correct classification of obesity 
using a cutoff of 30kg/m2 drops from 48.1 to 23.9% and 49.0 to 19.6%, in males and females in 
these two age groups.
Conclusions—Traditional measures poorly identify obesity in the elderly. In older adults, BMI 
may be a suboptimal marker for adiposity.
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INTRODUCTION
Obesity is a global public health crisis1 associated with considerable health risks that 
increase the risk of coronary artery disease, stroke, cancer and premature mortality2, 3. The 
importance of identifying obesity as a disease in a clinical care setting is critical to the 
management of such patients4. Accurate diagnosis of obesity in older adults is an essential 
first step in delivering effective treatment to older adults most at risk.
Body mass index (BMI) is the most common method to diagnose obesity in primary care 
and subspecialty settings. Population-based studies have proven the metabolic consequences 
of having a BMI≥25kg/m2 and the mortality risk of a BMI ≥30kg/m22, 3. These guidelines 
have been incorporated in public health campaigns and have become common practice. 
Other anthropometric measures have been suggested for use, including waist circumference, 
as they additionally place individuals at high overall cardiometabolic risk, independent of 
BMI5. However, they have not been fully recommended to be used in recent national 
guidelines4.
While BMI may reasonably predict adverse outcomes in global population-based adult 
studies, recent studies have demonstrated that traditional BMI cutoffs may in fact 
misrepresent the degree of adverse outcomes in older populations5, 6. This is partly 
explained by the changes observed in body composition occurring with aging7 including the 
gradual increase in fat mass, the decrease in muscle mass and quality or sarcopenia, and the 
degree of underlying systemic inflammation. Identifying the predictive validity and 
diagnostic accuracy of BMI in this older subpopulation is critically important to provide 
reasonable recommendations to front-line clinicians. The purpose of this study was to 
determine the diagnostic performance of BMI to identify obesity based on body fat in 
elderly subjects using established cutoffs for overweight and obesity. We also determined the 
differences in underlying metabolic abnormalities in those with varying degrees of body fat 
content using body composition measurements but not otherwise classified as having 
obesity.
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METHODS
The National Health and Nutrition Examination Surveys are cross-sectional surveys 
conducted by the Centers for Disease Prevention and Control since 1971. The survey 
samples non-institutionalized adults of the United States and oversamples minorities and 
elderly adults. It is a complex stratified multistage probability sampling design allowing 
generalizability of the results to the rest of the population. All of the survey contents and 
procedures are available online at http://www.cdc.gov/nchs/nhanes.htm (accessed February 
2015). Data for this analysis were limited to the 1999–2004 datasets. The survey has been 
approved by an internal Institutional Review Board, and was exempt from local review 
because of the de-identified nature of the results.
Of the 38,077 total participants screened, 31,125 were interviewed, and 29,402 were 
examined in a standardized mobile examination center. We limited our analysis to those 
aged 60 and older as the relationship between obesity and BMI is less clear in an elderly 
population. In the cohort aged ≥60years, 7,729 were screened, 5,607 (72.5%) were 
interviewed, and 4,984 (64.5%) were examined. All subjects included in our analysis had 
body composition data obtained by dual-energy X-ray absorptiometry (DEXA). There were 
4,984 participants fulfilling these criteria and were classified by race (non-Hispanic White, 
non-Hispanic Black, Hispanic, and Other), and by age group, where applicable (60–69.9, 
70–79.9, and ≥80years). All baseline demographic characteristics were assessed using a self-
report questionnaire.
Measurements were all performed on the right side of the body to the nearest 0.1cm, except 
where casts, amputations and other factors prevented such assessment. Height was measured 
using a stadiometer after deep inhalation, and weight was measured using an electronic 
digital scale, calibrated in kilograms. Body mass index was calculated as weight (kg) divided 
by height (m) squared. Waist circumference was measured in the standing position at the 
iliac crest, crossing the mid-axillary line, with the measuring tape placed around the trunk. 
Blood pressure was measured in the mobile examination center by a trained examiner 
following the latest recommendations of the American Heart Association Human Blood 
Pressure Determination by a mercury sphygmomanometer8. Determinations were recorded 
directly onto a computerized data collection form and the blood pressure reported to the 
examinee is that reported in this study. All DEXA data were obtained using a QDR-4500, 
Hologic scanner (Bedford, MA) by trained technicians. The procedure lasted roughly 3 
minutes. DEXA exclusions consisted of subjects who were ≥192.5cm or weighed ≥136.4kg 
in this subgroup. Metal objects, except false dentition and hearing aids, were removed. 
Overall fat mass, muscle mass, bone measurements, appendicular skeletal muscle mass of all 
limbs, and bone mineral content were assessed. Total body fat percent and lean mass percent 
were subsequently calculated. These techniques were similar in all NHANES cycles.
Detailed specimen collection and processing instructions are discussed in the NHANES 
Laboratory/Medical Technologists Procedures Manual located on the NHANES website 
(http://www.cdc.gov/nhanes). Vials were stored under appropriate frozen (−20°C) conditions 
until they were shipped for testing. Non-fasting routine biochemistries, including glucose, 
triglycerides were performed with a Hitachi Model 704 multichannel analyzer (Boehringer 
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Mannheim Diagnostics, Indianopolis, IN). Total cholesterol, HDL, triglycerides, and LDL 
cholesterol were shipped to Johns Hopkins University Lipoprotein Analytical Laboratory for 
testing. Blood specimens for fasting glucose, insulin, were processed, stored, and shipped to 
the University of Missouri-Columbia for analysis, and C-reactive protein was performed at 
the University of Washington. The homeostatic assessment model-1 was determined using 
published equations to determine insulin resistance and β-cell function9. HOMA-IR was 
calculated as: (fasting insulin × fasting glucose (mg/dL))/405. Homa-B was calculated as 
(360 × insulin)/(glucose-63), represented as a percentage.
Statistical Analysis
All data were merged and analyzed according to the policies and procedures outlined by 
NHANES. Baseline characteristics are presented as weighted means with standard errors for 
all continuous variables, and weighted percentages for categorical determinations. Because 
of the known differences in body composition7, baseline characteristics were stratified by 
sex. The gold standard assessment was considered body fat percent based on DEXA-
obtained adiposity to determine the diagnostic performance of BMI. Obesity diagnosis based 
on fat content measured with DEXA was defined as having body fat equal or greater than 
25% for males, and 35% for females10, based on values recommended by the American 
Association for Clinical Endocrinology and those used in our previous studies5, 6, 11. 
Subjects were also classified according to standard BMI cutoffs of 25kg/m2 and 30kg/m2 
representing overweight and obesity.
Diagnostic performance was assessed by determining sensitivity, specificity, positive and 
negative predictive values, and positive and negative likelihood ratios. Receiver operating 
characteristics curves were constructed for BMI to detect BF%-defined obesity for all 
subjects separately by sex and ethnicity. We additionally report the distribution of 
individuals with a normal BMI but elevated body fat and differences in metabolic variables 
in subjects whose BMI <30kg/m2 with differing sex-specific cutpoints of body fat and 
separately demonstrating cumulative distribution functions of percent body fat by BMI 
cutoff (30kg/m2) in both sexes. T-tests of unequal variances compared metabolic variables 
between these two groups in each sex. Replicates and data review were performed for 
quality assurance. All analyses were conducted using STATA v13 (College Station, TX) 
accounting for strata, primary sampling unit, and weighting. Separate weights were used for 
the fasting morning subsample. Interview weights were used according to NHANES 
procedures to account for the unequal probabilities of selection, participant non-response, 
non-reponse to the in-home interview and mobile center examination, and also were post-
stratified to match estimates of the US non-institutionalized adult population. A P value 
<0.05 was considered statistically significant and Bonferroni multiple comparison 
adjustments were performed when necessary.
RESULTS
Our final dataset consisted of 2,531 men and 2,453 females aged over 60 years, as indicated 
in Table 1. Mean BMI was 28.0 and 28.5kg/m2 in men and females, respectively, with 
28.9% and 34.3% of older adults classified as having obesity based on BMI. Based on body 
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fat, 87.5 and 89.1% of men and females are classified as having obesity. In those aged 
≥80years, a BMI ≥30kg/m2 had a very low sensitivity, negative predictive value, and 
concordance rates as compared to younger cohorts. Notably, both lean mass and 
appendicular skeletal mass were higher in men than females.
Table 2A represents the diagnostic performance for a BMI of 25 and 30kg/m2. As the cutoff 
for BMI increases from 25 to 30kg/m2, the sensitivity drops, and the specificity increases in 
both sexes. Correct classification of obesity drops markedly with age with both cutoffs, but 
is markedly lower using a BMI≥30kg/m2. The ideal BMI to identify obesity in men and 
females is 24.91 and 24.1kg/m2, respectively (Figure 1). Table 2B represents using standard 
WC cutoffs and Figure 2 Represents the receiver operator curves noting the optimal 
thresholds are 97.6 and 87.4cm, respectively. In Table 3, we present data on metabolic 
variables in the subset of subjects in each sex with a BMI <30kg/m2 and a low WC stratified 
by body fat. Across both non-fasting and fasting samples, a number of indicators suggest the 
heterogeneity of those with a BMI<30kg/m2 with regard to cardiometabolic dysfunction. 
These differences were not observed in females with a low WC. Cumulative distribution 
functions are presented in Figure 3. We present in Figure 4, the distribution and weighted 
prevalence in those with a BMI<30kg/m2 and body fat. The line designates the standard 
body fat cutoff for obesity (men: 25%; females: 35%). Lastly, Table 4 represents the 
adjusted correlation coefficients between BMI and body fat, lean mass and appendicular 
skeletal mass, both by sex, and by age-group.
DISCUSSION
Our study highlights the challenges with utilizing BMI as the most widely used and accepted 
method to diagnose obesity in clinical care setting, particularly in older adults. With the 
changes observed in body composition in this patient population, our data provides an 
opportunity to caution clinicians in solely relying on this anthropometric measure for 
counseling patients on reducing their weight and lowering their cardiovascular risk.
To our knowledge, this is the first analysis using nationally representative data to determine 
the diagnostic performance of BMI using DEXA as the gold standard and that focuses 
specifically on older adults. Previous studies using DEXA data from NHANES have focused 
on those with and without physical limitations12. These authors noted excellent specificity 
but poor sensitivity, in addition to considerable misclassification based on body fat percent. 
Flegal’s analysis using differing anthropometric indices, including BMI, WC, waist hip 
circumference, and waist to stature ratio, focused predominantly on correlation coefficients 
and agreement between metrics13, rather than focusing on diagnostic accuracy using our the 
methods utilized in this analysis. Our group has explored this relationship previously14 in a 
systematic review that demonstrated BMI≥30kg/m2 had an overall pooled sensitivity of 50% 
and specificity of 90%. A specific analysis that used bioelectrical impedance demonstrated 
the changes observed in diagnostic accuracy in the general population using similar cutoffs, 
albeit in a general population11. In this study, sensitivity of a BMI≥30kg/m2 for obesity 
peaked in the 40–49.9year age group at 44% in men, and in the 50–59.9years at 54% in 
females. This dropped to 27% and 43% in the 70–79year age group, respectively. Specificity 
remained high in both sexes (>90%), although negative predictive value dropped with age 
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from 70% and 69% in males and females in the 20–29year age group, to 51% in both sexes 
in the 70–79year group. For all subjects, area under the curve was 0.88 with an ideal BMI of 
25.5kg/m2 (sensitivity 83%, specificity 76%). However, BIA is highly inaccurate in older 
adults and can be influenced by food consumption, exercise, ethnicity and certain medical 
conditions. As body water content differs in older adults, this may also influence its 
precision and accuracy. Others have used body-plethysmography and have observed similar 
results15. DEXA-scanning does not have these limitations and has less bias than BIA16 and 
in older adults could be a better modality for the ascertainment of body fat. Our results are 
similar to others that have demonstrated the poor discrimination between body fat % in 
populations with coronary artery disease17. In an Australian study, one group suggested the 
importance of gender and age-specific thresholds when using BMI to indicate adiposity18. 
Notably, BMI is even inaccurate in assessing adiposity in pediatric populations19.
Our analysis proves that the diagnostic accuracy of BMI is markedly poor in both sexes with 
increased age, reflected by the lower concordance indices. The ideal cutpoint for BMI in this 
population-based cohort is ~25kg/m2 in both sexes, a cutoff markedly lower than the current 
criterion to diagnose obesity. A BMI of 25kg/m2 is associated with the lowest mortality 
point in a number of longitudinal studies. In fact, our results, coupled with those linking a 
BMI ~26–27kg/m2 with the lowest mortality, suggest that traditional BMI cutoffs are likely 
inaccurate and conceivably should be revisited. While the degree of correlation was 
satisfactory between BMI, body fat and measures of muscle mass, we believe that the 
interplay between muscle mass and fat is likely to not only impact the degree of functional 
capacity in older adults, but may obscure the adequacy of using BMI as a simple measure of 
adiposity. Additionally, the majority of subjects with a BMI>25kg/m2 have obesity based on 
body fat.
We believe that while BMI has its shortcomings, it still may be a useful measure to use. For 
instance, in older adults, previous studies have predicted a direct relationship between 
obesity, disability and mortality2, 20. Recent consensus statements from the Foundation for 
the National Institutes of Health Sarcopenia Project21 have indeed incorporated BMI in grip 
strength cutoffs for clinical identification of at risk subjects for weakness. However, its 
utility in clinical practice for obesity alone should be used with great caution informed by 
our study findings. Two major initiatives rely on BMI in an older adult population, including 
the Physician Quality reporting measures22, and the Medicare Obesity Benefit23. Our data 
proves the limitations of using this measure, but also demonstrate that the majority of older 
people in the United States population that have obesity based on body composition, may 
otherwise be classified as not having obesity based on a BMI<30kg/m25. We purposefully 
presented discordant cases in Table 3 to determine the difference in metabolic profiles in 
those with a non-obese BMI but different body fat composition. This subset analysis proves 
that subjects with obesity mischaracterized by BMI (BMI<30kg/m2) have differing 
metabolic profiles and there may be sex-specific differences based on central obesity. 
Additionally, there are certain populations where an elevated BMI may lead to improved 
outcomes, a phenomenon known as the obesity paradox24. Strongly encouraging the sole use 
of BMI in practice-based settings may target inappropriate populations or outcomes and 
other measures including WC should be considered. In older adults, adiposity localized 
centrally, and WC may be a possible alternative for adiposity assessment. While DEXA may 
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be widely available for measurement of body composition, in the United States, it is not a 
reimbursable procedure for this indication and hence the need to consider alternative 
anthropometrics. Physical function and quality of life are important patient-specific 
outcomes in older adults and targeted outcomes of primary care obesity interventions in this 
population should alter the focus from weight or BMI to such measures as advocated by 
others23, 25.
As with any cross-sectional study, we acknowledge the intrinsic methodological limitations 
of NHANES. While there is oversampling of older adults, we are limited by the number of 
subjects in the older age categories. Additionally, our results can only be extrapolated to 
community-based adults, and not institutionalized adults. While body fat % is considered the 
gold standard in defining obesity, the cutoffs appear to be arbitrary. While other authors have 
repeatedly used these cutoffs and inadvertently referred to the 1995 WHO Technical 
Report26, there remains no scientific rationale for using such cutoffs other than expert 
opinion27–29. Future validation threshold studies by age, gender and race are critically 
needed.
A disadvantage of categorizing a continuous variable into categories is not only the loss of 
study power, but values slightly above the threshold may have only incremental and modest 
long-term risk, potentially resulting in overdiagnosis30. Misclassification is possible as well, 
and this has implications for public health in the identification and management of higher 
risk populations. While DEXA scanning is a reasonably inexpensive modality to routinely 
assess body composition, it is performed for unrelated clinical indications and not for this 
sole purpose. Future research and advocacy would provide more accurate assessments of 
obesity status, than present anthropometric measures. Its accuracy in older adults is superior 
to that of bioelectrical impedance, in that the latter may underestimate truncal obesity and is 
highly dependent on water content, making it suboptimal for use in older adults.
Our study confirms using DEXA-based body composition measures that BMI suboptimally 
identifies adiposity. While gold-standard methods such as CT and MRI may provide 
accurate whole-body and regional assessment of fat and muscle31, these are clinically 
impractical and costly for routine assessment. We suggest that accurate measurements of 
adiposity be considered using DEXA in older adults, particularly when this test is performed 
for other indications, such as osteoporosis screening or monitoring. This can eliminate the 
challenges observed with using BMI as a clinical tool and its lack of diagnostic accuracy. 
Future studies should evaluate the added cost-burden compared to the information that this 
modality can provide to a clinician.
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Figure 1. 
A, B Receiver Operator Curves for body mass index (BMI) for all subjects aged ≥60years in 
the National Health and Nutrition Examination Survey 1999-2004 sample included in this 
analysis to detect body fat percentage by sex. Men - Figure a; Females – Figure b.
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Figure 2. 
A, B Receiver Operator Curves for waist circumference (WC) for all subjects aged ≥60years 
in the National Health and Nutrition Examination Survey 1999–2004 sample included in this 
analysis to detect body fat percentage by sex. Men - Figure a; Females – Figure b
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Figure 3. 
A, B Cumulative Distribution Functions of percent body fat in men (panel A) and females 
(panel B) in subjects with a body mass index ≥30kg/m2 and <30kg/m2. Vertical lines 
represent percent body fat cutoffs for males (25%) and females (35%).
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Figure 4. 
Variations in percent body fat in men (panel a) and females (panel B) in subjects with a body 
mass index <30kg/m2). Line represents body fat cutoffs for each sex (≥25% in men; ≥35% 
in females)
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